{
  "address1": "333 Lakeside Drive",
  "city": "Foster City",
  "state": "CA",
  "zip": "94404",
  "country": "United States",
  "phone": "650 574 3000",
  "fax": "650 522 5853",
  "website": "https://www.gilead.com",
  "industry": "Drug Manufacturers\u2014General",
  "industryDisp": "Drug Manufacturers\u2014General",
  "sector": "Healthcare",
  "sectorDisp": "Healthcare",
  "longBusinessSummary": "Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Merck & Co, Inc. and Tentarix Biotherapeutics Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.",
  "fullTimeEmployees": 17000,
  "companyOfficers": [
    {
      "maxAge": 1,
      "name": "Mr. Daniel P.  O'Day",
      "age": 58,
      "title": "Chairman & CEO",
      "yearBorn": 1964,
      "fiscalYear": 2022,
      "totalPay": 7267338,
      "exercisedValue": 0,
      "unexercisedValue": 9635551
    },
    {
      "maxAge": 1,
      "name": "Mr. Andrew D. Dickinson",
      "age": 52,
      "title": "Exec. VP & CFO",
      "yearBorn": 1970,
      "fiscalYear": 2022,
      "totalPay": 2935112,
      "exercisedValue": 0,
      "unexercisedValue": 5436829
    },
    {
      "maxAge": 1,
      "name": "Ms. Deborah H. Telman",
      "age": 57,
      "title": "Exec. VP of Corp. Affairs, Gen. Counsel & Corp. Sec.",
      "yearBorn": 1965,
      "fiscalYear": 2022,
      "totalPay": 2323080,
      "exercisedValue": 0,
      "unexercisedValue": 0
    },
    {
      "maxAge": 1,
      "name": "Ms. Johanna  Mercier",
      "age": 52,
      "title": "Chief Commercial Officer",
      "yearBorn": 1970,
      "fiscalYear": 2022,
      "totalPay": 3322200,
      "exercisedValue": 0,
      "unexercisedValue": 3864125
    },
    {
      "maxAge": 1,
      "name": "Dr. Merdad V. Parsey M.D., Ph.D.",
      "age": 59,
      "title": "Chief Medical Officer",
      "yearBorn": 1963,
      "fiscalYear": 2022,
      "totalPay": 3074714,
      "exercisedValue": 0,
      "unexercisedValue": 3047349
    },
    {
      "maxAge": 1,
      "name": "Ms. Sandra  Patterson",
      "age": 55,
      "title": "Sr. VP, Corp. Controller & Principal Accounting Officer",
      "yearBorn": 1967,
      "exercisedValue": 0,
      "unexercisedValue": 0
    },
    {
      "maxAge": 1,
      "name": "Ms. Jacquie  Ross C.F.A.",
      "title": "VP of Investor Relations",
      "exercisedValue": 0,
      "unexercisedValue": 0
    },
    {
      "maxAge": 1,
      "name": "Ms. Jyoti K. Mehra",
      "age": 46,
      "title": "Exec. VP of HR",
      "yearBorn": 1976,
      "exercisedValue": 0,
      "unexercisedValue": 0
    },
    {
      "maxAge": 1,
      "name": "Dr. Michael  Quigley Ph.D.",
      "title": "Sr. VP of Research Biology",
      "exercisedValue": 0,
      "unexercisedValue": 0
    },
    {
      "maxAge": 1,
      "name": "Dr. Linda Slanec Higgins Ph.D.",
      "age": 60,
      "title": "Sr. VP of Research, Innovation & Portfolio",
      "yearBorn": 1962,
      "exercisedValue": 0,
      "unexercisedValue": 0
    }
  ],
  "auditRisk": 3,
  "boardRisk": 4,
  "compensationRisk": 3,
  "shareHolderRightsRisk": 1,
  "overallRisk": 1,
  "governanceEpochDate": 1693526400,
  "compensationAsOfEpochDate": 1672444800,
  "maxAge": 86400,
  "priceHint": 2,
  "previousClose": 75.27,
  "open": 74.76,
  "dayLow": 74.35,
  "dayHigh": 75.61,
  "regularMarketPreviousClose": 75.27,
  "regularMarketOpen": 74.76,
  "regularMarketDayLow": 74.35,
  "regularMarketDayHigh": 75.61,
  "dividendRate": 3.0,
  "dividendYield": 0.0399,
  "exDividendDate": 1694649600,
  "payoutRatio": 0.68050003,
  "fiveYearAvgDividendYield": 3.91,
  "beta": 0.386583,
  "trailingPE": 17.24368,
  "forwardPE": 11.030882,
  "volume": 4351652,
  "regularMarketVolume": 4351652,
  "averageVolume": 5546593,
  "averageVolume10days": 5634580,
  "averageDailyVolume10Day": 5634580,
  "bid": 75.01,
  "ask": 75.02,
  "bidSize": 1400,
  "askSize": 900,
  "marketCap": 93463207936,
  "fiftyTwoWeekLow": 61.45,
  "fiftyTwoWeekHigh": 89.74,
  "priceToSalesTrailing12Months": 3.4133084,
  "fiftyDayAverage": 77.233,
  "twoHundredDayAverage": 80.6088,
  "trailingAnnualDividendRate": 2.96,
  "trailingAnnualDividendYield": 0.0393251,
  "currency": "USD",
  "enterpriseValue": 111871500288,
  "profitMargins": 0.20028,
  "floatShares": 1244456835,
  "sharesOutstanding": 1246009984,
  "sharesShort": 18250145,
  "sharesShortPriorMonth": 18841286,
  "sharesShortPreviousMonthDate": 1690761600,
  "dateShortInterest": 1693440000,
  "sharesPercentSharesOut": 0.0146,
  "heldPercentInsiders": 0.001,
  "heldPercentInstitutions": 0.86845,
  "shortRatio": 3.46,
  "shortPercentOfFloat": 0.0164,
  "impliedSharesOutstanding": 1246009984,
  "bookValue": 16.967,
  "priceToBook": 4.420935,
  "lastFiscalYearEnd": 1672444800,
  "nextFiscalYearEnd": 1703980800,
  "mostRecentQuarter": 1688083200,
  "earningsQuarterlyGrowth": -0.087,
  "netIncomeToCommon": 5484000256,
  "trailingEps": 4.35,
  "forwardEps": 6.8,
  "pegRatio": 2.91,
  "lastSplitFactor": "2:1",
  "lastSplitDate": 1359331200,
  "enterpriseToRevenue": 4.086,
  "enterpriseToEbitda": 9.197,
  "52WeekChange": 0.20741093,
  "SandP52WeekChange": 0.18466556,
  "lastDividendValue": 0.75,
  "lastDividendDate": 1694649600,
  "exchange": "NMS",
  "quoteType": "EQUITY",
  "symbol": "GILD",
  "underlyingSymbol": "GILD",
  "shortName": "Gilead Sciences, Inc.",
  "longName": "Gilead Sciences, Inc.",
  "firstTradeDateEpochUtc": 696090600,
  "timeZoneFullName": "America/New_York",
  "timeZoneShortName": "EDT",
  "uuid": "8659e669-8ec5-3b0f-9929-db5db506231f",
  "messageBoardId": "finmb_29002",
  "gmtOffSetMilliseconds": -14400000,
  "currentPrice": 75.01,
  "targetHighPrice": 108.89,
  "targetLowPrice": 66.65,
  "targetMeanPrice": 85.46,
  "targetMedianPrice": 84.95,
  "recommendationMean": 2.4,
  "recommendationKey": "buy",
  "numberOfAnalystOpinions": 24,
  "totalCash": 7097999872,
  "totalCashPerShare": 5.697,
  "ebitda": 12163999744,
  "totalDebt": 25245999104,
  "quickRatio": 0.811,
  "currentRatio": 1.023,
  "totalRevenue": 27381999616,
  "debtToEquity": 119.683,
  "revenuePerShare": 21.871,
  "returnOnAssets": 0.09774,
  "returnOnEquity": 0.26348,
  "grossProfits": 21624000000,
  "freeCashflow": 9621499904,
  "operatingCashflow": 9511999488,
  "earningsGrowth": -0.088,
  "revenueGrowth": 0.054,
  "grossMargins": 0.79424006,
  "ebitdaMargins": 0.44423,
  "operatingMargins": 0.35753,
  "financialCurrency": "USD",
  "trailingPegRatio": 0.5068
}